Dr Glenn David Goldman, MD - Medicare Dermatology in Colchester, VT

Dr Glenn David Goldman, MD is a medicare enrolled "Dermatology - Mohs-micrographic Surgery" physician in Colchester, Vermont. He went to Js Weill Medical College, Cornell University and graduated in 1991 and has 33 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Four Seasons Dermatology Llc and his current practice location is 354 Mountain View Dr Ste 300, Colchester, Vermont. You can reach out to his office (for appointments etc.) via phone at (802) 864-0192.

Dr Glenn David Goldman is licensed to practice in Vermont (license number 0420009351) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1992717458.

Contact Information

Dr Glenn David Goldman, MD
354 Mountain View Dr Ste 300,
Colchester, VT 05446-5988
(802) 864-0192
(802) 860-4919



Physician's Profile

Full NameDr Glenn David Goldman
GenderMale
SpecialityDermatology
Experience33 Years
Location354 Mountain View Dr Ste 300, Colchester, Vermont
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Glenn David Goldman attended and graduated from Js Weill Medical College, Cornell University in 1991
  NPI Data:
  • NPI Number: 1992717458
  • Provider Enumeration Date: 08/13/2006
  • Last Update Date: 03/05/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 6204889496
  • Enrollment ID: I20050228000885

Medical Identifiers

Medical identifiers for Dr Glenn David Goldman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1992717458NPI-NPPES
0VN1395MedicaidVT
01669910MedicaidNY

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ND0101XDermatology - Mohs-micrographic Surgery 0420009351 (Vermont)Primary
207N00000XDermatology 0420009351 (Vermont)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Univ. Of Vermont - Fletcher Allen Health CareBurlington, VTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Four Seasons Dermatology Llc882006294611

News Archive

Ingen Technologies receives CCR confirmation, listing in Military Purchasing Directory

Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).

Researchers to discuss effects of alcohol on immune system at AIRIG meeting

On Nov. 22, leading alcohol researchers from the United States and Europe will present the latest findings on how alcohol impairs the immune system.

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

Fast growing Scottish biotech company Sistemic Ltd today announced that it had closed a series A funding round with lead investors ChimeraBio and the Scottish Enterprise Scottish Co-Investment Fund. The company will use the funding to further develop its proprietary SistemRNA compound-centric drug discovery technology. Using SistemRNA shortens the odds in drug discovery by enabling far more accurate prediction of potential drug indications, interactions and side effects.

Individuals with synovitis may have greater risk for cartilage damage, shows study

In an Arthritis & Rheumatology study of 221 patients with knee osteoarthritis and meniscal tears, increases in inflammation of the synovial membrane-whether persistently extensive or intermittent-were linked with cartilage damage over time.

U.S.-funded initiative associated with reductions in maternal and newborn mortality in Indonesia

A U.S.-funded initiative to improve quality of care and referrals during pregnancy and childbirth in Indonesia resulted in significant reductions in maternal and newborn mortality at participating hospitals, according to a new study led by scientists at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Glenn David Goldman allows following entities to bill medicare on his behalf.
Entity NameUniversity Of Vermont Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659309615
PECOS PAC ID: 3779491071
Enrollment ID: O20040406001047

News Archive

Ingen Technologies receives CCR confirmation, listing in Military Purchasing Directory

Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).

Researchers to discuss effects of alcohol on immune system at AIRIG meeting

On Nov. 22, leading alcohol researchers from the United States and Europe will present the latest findings on how alcohol impairs the immune system.

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

Fast growing Scottish biotech company Sistemic Ltd today announced that it had closed a series A funding round with lead investors ChimeraBio and the Scottish Enterprise Scottish Co-Investment Fund. The company will use the funding to further develop its proprietary SistemRNA compound-centric drug discovery technology. Using SistemRNA shortens the odds in drug discovery by enabling far more accurate prediction of potential drug indications, interactions and side effects.

Individuals with synovitis may have greater risk for cartilage damage, shows study

In an Arthritis & Rheumatology study of 221 patients with knee osteoarthritis and meniscal tears, increases in inflammation of the synovial membrane-whether persistently extensive or intermittent-were linked with cartilage damage over time.

U.S.-funded initiative associated with reductions in maternal and newborn mortality in Indonesia

A U.S.-funded initiative to improve quality of care and referrals during pregnancy and childbirth in Indonesia resulted in significant reductions in maternal and newborn mortality at participating hospitals, according to a new study led by scientists at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 3 days ago

Entity NameFour Seasons Dermatology Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1790737393
PECOS PAC ID: 8820062946
Enrollment ID: O20040824001173

News Archive

Ingen Technologies receives CCR confirmation, listing in Military Purchasing Directory

Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).

Researchers to discuss effects of alcohol on immune system at AIRIG meeting

On Nov. 22, leading alcohol researchers from the United States and Europe will present the latest findings on how alcohol impairs the immune system.

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

Fast growing Scottish biotech company Sistemic Ltd today announced that it had closed a series A funding round with lead investors ChimeraBio and the Scottish Enterprise Scottish Co-Investment Fund. The company will use the funding to further develop its proprietary SistemRNA compound-centric drug discovery technology. Using SistemRNA shortens the odds in drug discovery by enabling far more accurate prediction of potential drug indications, interactions and side effects.

Individuals with synovitis may have greater risk for cartilage damage, shows study

In an Arthritis & Rheumatology study of 221 patients with knee osteoarthritis and meniscal tears, increases in inflammation of the synovial membrane-whether persistently extensive or intermittent-were linked with cartilage damage over time.

U.S.-funded initiative associated with reductions in maternal and newborn mortality in Indonesia

A U.S.-funded initiative to improve quality of care and referrals during pregnancy and childbirth in Indonesia resulted in significant reductions in maternal and newborn mortality at participating hospitals, according to a new study led by scientists at the Johns Hopkins Bloomberg School of Public Health.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Glenn David Goldman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Glenn David Goldman, MD
358 Chamberlin Ln,
Williston, VT 05495-4406

Ph: () -
Dr Glenn David Goldman, MD
354 Mountain View Dr Ste 300,
Colchester, VT 05446-5988

Ph: (802) 864-0192

News Archive

Ingen Technologies receives CCR confirmation, listing in Military Purchasing Directory

Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8 billion respiratory market, announced today that it has received a letter of confirmation from the Armed Services Association in Washington, D.C. stating that the company is now registered with the U.S. Central Contractor Registry (CCR), which qualifies it to do business with the U.S. Department of Defense (DoD).

Researchers to discuss effects of alcohol on immune system at AIRIG meeting

On Nov. 22, leading alcohol researchers from the United States and Europe will present the latest findings on how alcohol impairs the immune system.

Sistemic to develop SistemRNA compound-centric drug discovery technology with closed series A funds

Fast growing Scottish biotech company Sistemic Ltd today announced that it had closed a series A funding round with lead investors ChimeraBio and the Scottish Enterprise Scottish Co-Investment Fund. The company will use the funding to further develop its proprietary SistemRNA compound-centric drug discovery technology. Using SistemRNA shortens the odds in drug discovery by enabling far more accurate prediction of potential drug indications, interactions and side effects.

Individuals with synovitis may have greater risk for cartilage damage, shows study

In an Arthritis & Rheumatology study of 221 patients with knee osteoarthritis and meniscal tears, increases in inflammation of the synovial membrane-whether persistently extensive or intermittent-were linked with cartilage damage over time.

U.S.-funded initiative associated with reductions in maternal and newborn mortality in Indonesia

A U.S.-funded initiative to improve quality of care and referrals during pregnancy and childbirth in Indonesia resulted in significant reductions in maternal and newborn mortality at participating hospitals, according to a new study led by scientists at the Johns Hopkins Bloomberg School of Public Health.

Read more News

› Verified 3 days ago


Dermatology Doctors in Colchester, VT

Anita Louise Licata, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 354 Mountain View Dr, Suite 300, Colchester, VT 05446
Phone: 802-864-0192    Fax: 802-860-4919
Ms. Mary B Harkin, N.P.
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 354 Mountain View Dr, Suite 300, Colchester, VT 05446
Phone: 802-864-0192    Fax: 802-860-4919

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.